Molecular Biomarkers are alteration expressions of structures of nucleic acids, proteins and proteoglycans Cancer diagnosis is currently undergoing a standard shift with the incorporation of molecular biomarkers as part of routine diagnostic panel. Molecular alteration ranges from the DNA, RNA, microRNAs (miRNAs) and proteins. The miRNAs are recently discovered small non-coding endogenous single-stranded RNAs that critically regulates the development, invasion and metastasis of cancer. They are altered in cancers and have the potential to serve as diagnostic markers for cancer.
Related Conferences: International Conference on Molecular Biology and Stem Cells, November 19-20, 2018 at Paris, France; 12th International Conference on Cancer Stem Cells and Oncology Research, March 15-17, 2019 at Rome, Italy; 9th European Congress on Breast Cancer, Women’s health and Therapeutics, February 25-27, 2019; 2nd World Congress on Stem Cells and Regenerative Medicine, March 14-15, 2019, London, UK
Related Associations: The Biomarkers consortium, International Society for Oncology and Biomarkers, Biomarkers profile corporation, World Molecular Imaging Society, European Society of Molecular Imaging, Biomarkers Society, Society of Nuclear Medicine and Molecular Imaging
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
